ATE516367T1 - USE OF A GENETIC MODIFICATION IN THE HUMAN GNAS GENE TO PREDICT RISK OF DISEASE, DISEASE PROCESSES AND TO PREDICT RESPONSE TO DISEASE THERAPIES - Google Patents

USE OF A GENETIC MODIFICATION IN THE HUMAN GNAS GENE TO PREDICT RISK OF DISEASE, DISEASE PROCESSES AND TO PREDICT RESPONSE TO DISEASE THERAPIES

Info

Publication number
ATE516367T1
ATE516367T1 AT04712508T AT04712508T ATE516367T1 AT E516367 T1 ATE516367 T1 AT E516367T1 AT 04712508 T AT04712508 T AT 04712508T AT 04712508 T AT04712508 T AT 04712508T AT E516367 T1 ATE516367 T1 AT E516367T1
Authority
AT
Austria
Prior art keywords
disease
predict
genetic modification
therapies
processes
Prior art date
Application number
AT04712508T
Other languages
German (de)
Inventor
Ulrich Frey
Winfried Siffert
Original Assignee
Univ Duisburg Essen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32797558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE516367(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Duisburg Essen filed Critical Univ Duisburg Essen
Priority claimed from PCT/EP2004/001563 external-priority patent/WO2004076690A2/en
Application granted granted Critical
Publication of ATE516367T1 publication Critical patent/ATE516367T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
AT04712508T 2003-02-19 2004-02-19 USE OF A GENETIC MODIFICATION IN THE HUMAN GNAS GENE TO PREDICT RISK OF DISEASE, DISEASE PROCESSES AND TO PREDICT RESPONSE TO DISEASE THERAPIES ATE516367T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10307114 2003-02-19
DE10348600A DE10348600A1 (en) 2003-02-19 2003-10-20 Use of a gene modification in the human GNAS1 gene to predict disease risks, disease courses and to predict the response to disease therapies
PCT/EP2004/001563 WO2004076690A2 (en) 2003-02-19 2004-02-19 Use of a mutation in the human gnas gene for predicting risks of disease, courses of diseases, and for predicting the response to treatments of disease

Publications (1)

Publication Number Publication Date
ATE516367T1 true ATE516367T1 (en) 2011-07-15

Family

ID=32797558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04712508T ATE516367T1 (en) 2003-02-19 2004-02-19 USE OF A GENETIC MODIFICATION IN THE HUMAN GNAS GENE TO PREDICT RISK OF DISEASE, DISEASE PROCESSES AND TO PREDICT RESPONSE TO DISEASE THERAPIES

Country Status (2)

Country Link
AT (1) ATE516367T1 (en)
DE (1) DE10348600A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015171370A1 (en) 2014-05-05 2015-11-12 Medtronic, Inc. Methods and compositions for scd, crt, crt-d, or sca therapy identification and/or selection

Also Published As

Publication number Publication date
DE10348600A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
SG142154A1 (en) Methods for genomic analysis
DE602004020194D1 (en) FUNCTION AND TO OPTIMIZE THE CARDIAL STIMULATION INTERVALS BASED ON LEFT VENTRICULAR WALL MOVEMENT
ATE410126T1 (en) DENTAL NAPDS WITH TAPS AND MEANS TO RELIEF STRESS
DE602005025106D1 (en) METHODS OF MEDICATION REVIEW BASED ON VITRO DIFFERENTIATED CELLS
DE602006008827D1 (en) HERBICIDESIS GIVING GENES GRG23 AND GRG51
ATE392475T1 (en) ELONGASE GENES AND THEIR USE
DE602005023748D1 (en) CHROMIUM AND ACTIVE ELEMENT MODIFIED PLATINUM ALUMINIDE COATINGS
DE60134866D1 (en) USE OF IMIDAZOCHINOLINAMINES AS ADJUVANTIES IN DNA VACCINATION
DE602004009171D1 (en) METHOD AND DEVICE FOR IMPROVING VENTRICULAR STATUS USING THE FORCE-INTERVAL RELATIONSHIP
DE60203463D1 (en) Facilitating the determination of physical information related to limitations of daily life in relationship
EP1910569A4 (en) Genemap of the human genes associated with longevity
SG114670A1 (en) New fluorescent genetic fragments and fish
WO2008014400A3 (en) Crohn disease susceptibility gene
WO2002074992A3 (en) Phosphodiesterase 4d genes related to human stroke
DE602005000024D1 (en) Collection Aid Management System, Auxiliary Wiz Management Information Management System, and Auxiliary Ways Information Management Method
DE60317693D1 (en) METHOD AND USE OF THERMOSTABILES RNA LIGASES
ATE465413T1 (en) USE OF ADAM 12 TO DIAGNOSE PREECLAMPSIA
DE602004019783D1 (en) THE RE-IDENTIFICATION OF A PLANT AWARDING GENE AND USE THEREOF
DE60322052D1 (en) N-ACYLAMINOACETONITRIL DERIVATIVES AND THEIR USE FOR THE CONTROL OF PARASITES
DE502005002035D1 (en) Use of a liquid for the treatment of hard metals
ATE516367T1 (en) USE OF A GENETIC MODIFICATION IN THE HUMAN GNAS GENE TO PREDICT RISK OF DISEASE, DISEASE PROCESSES AND TO PREDICT RESPONSE TO DISEASE THERAPIES
DE60141871D1 (en) Oligonucleotide labels and their use
ATE475315T1 (en) AGENTS FOR THE BIOLOGICAL CONTROL OF FUNGAL PLANT DISEASES
DE602004029922D1 (en) DEVICE FOR OPTIMIZING AND EVALUATING RESPONSE TO EXTRASYSTOLIC STIMULATION THERAPY (ESS)
DE502004001713D1 (en) Wax dispersions for use in / as body and hair care products